Begriffe, Krankheiten, Einrichtungen u.v.m., verknüpft mit dem zuständigen Bereich.
Im Menüpunkt "Übersicht" sind Einrichtungen unter verschiedenen Gesichtspunkten gruppiert: Kliniken, Abteilungen, Institute, Zentrale Einrichtungen und ähnliches.
Wichtigste aktuelle Veröffentlichungen
C. Theilacker, I.Sava, P. Sanchez-Carballo, Y. Bao, A. Kropec, E. Grohmann, O. Holst, J. Huebner. 2011. Deletion of the glycosyltransferase bgsB of Enterococcus faecalis leads to a complete loss of glycolipids from the cell membrane and to impaired biofilm formation. BMC Microbiol 11, 67.
C. Theilacker, Z. Kaczynski, A. Kropec, I. Sava, L. Ye, A. Bychowska, O. Holst, and J. Huebner. 2011. Serodiversity of Opsonic Antibodies against *Enterococcus faecalis* - Glycans of the Cell Wall Revisited. PLoS ONE 6: e17839 (2011)
C.Theilacker, D. Jonas, J. Huebner, H. Bertz, and W. Kern. 2009. Outcomes of Invasive Infection due to Vancomycin-Resistant *Enterococcus faecium* during a Recent Outbreak. Infection 37:540-3.
I. G. Sava, F. Zhang, I. Toma, C. Theilacker, B. Li, T. F. Baumert, O. Holst, R. J. Linhardt, and J. Huebner. 2009. Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells. J Biol Chem 284:18194-18201.
C. Theilacker, P. Sanchez-Carballo, I. Toma, F. Fabretti, I. Sava, A. Kropec, O. Holst, and J. Huebner. 2009. Glycolipids are involved in biofilm accumulation and prolonged bacteraemia in *Enterococcus faecalis*. Mol Microbiol 71:1055-1069.
P. Henneke, S. Dramsi, G. Mancuso, K. Chraibi, E. Pellegrini, C. Theilacker, J. Hübner, S. Santos-Sierra, G. Teti, D. T. Golenbock, C. Poyart, and P. Trieu-Cuot. 2008. Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. J Immunol 180:6149-6158.
C. Theilacker, Z. Kaczynski, A. Kropec, F. Fabretti, T. Sange, O. Holst, and J. Huebner. 2006. Opsonic antibodies to *Enterococcus faecalis* strain 12030 are directed against lipoteichoic acid. Infect Immun 74:5703-5712
F. Fabretti, C. Theilacker, L. Baldassarri, Z. Kaczynski, A. Kropec, O. Holst, and J. Huebner. 2006. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect Immun 74:4164-4171.
G. B. Pier, D. Boyer, M. Preston, F. T. Coleman, N. Llosa, S. Mueschenborn-Koglin, C. Theilacker, H. Goldenberg, J. Uchin, G. P. Priebe, M. Grout, M. Posner, and L. Cavacini. 2004. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J Immunol 173:5671-5678.
C. Theilacker, F. T. Coleman, S. Mueschenborn, N. Llosa, M. Grout, and G.B. Pier. 2003. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Infect Immun 71:3875-3884.
